Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment

A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and t...

Full description

Bibliographic Details
Main Authors: E. Łyżwa, M. Sobiecka, K. Lewandowska, I. Siemion-Szcześniak, I. Barańska, M. Klatt, R. Langfort, M. Szturmowicz, W. Tomkowski
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/3/693
_version_ 1797608601880100864
author E. Łyżwa
M. Sobiecka
K. Lewandowska
I. Siemion-Szcześniak
I. Barańska
M. Klatt
R. Langfort
M. Szturmowicz
W. Tomkowski
author_facet E. Łyżwa
M. Sobiecka
K. Lewandowska
I. Siemion-Szcześniak
I. Barańska
M. Klatt
R. Langfort
M. Szturmowicz
W. Tomkowski
author_sort E. Łyżwa
collection DOAJ
description A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and the need for repeated antiviral treatment. Monoclonal antibodies against CD20, which are used, among other things, in the therapy of chronic lymphocytic leukaemia and follicular lymphoma, can induct immunosuppression. We present a case report of a patient with follicular lymphoma, treated with obinutuzumab, who was diagnosed with prolonged, ongoing SARS-CoV-2 infection and related organizing pneumonia. The recognition and the treatment were challenging which makes this case noteworthy. Antiviral therapy with several medications was administrated to our patient and their temporary, positive effect was observed. Moreover, high-dose intravenous immunoglobulin was applied, because slowly decreasing IgM and IgG levels were observed. The patient also received standard treatment of organizing pneumonia. We believe that such a complex approach can create an opportunity for recovery. Physicians should be conscious of the course and treatment possibilities facing similar cases.
first_indexed 2024-03-11T05:46:52Z
format Article
id doaj.art-35b73ae83c134de49bd5688a8ce79567
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T05:46:52Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-35b73ae83c134de49bd5688a8ce795672023-11-17T14:23:00ZengMDPI AGViruses1999-49152023-03-0115369310.3390/v15030693Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and TreatmentE. Łyżwa0M. Sobiecka1K. Lewandowska2I. Siemion-Szcześniak3I. Barańska4M. Klatt5R. Langfort6M. Szturmowicz7W. Tomkowski81st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, PolandDepartment of Radiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, PolandDepartment of Microbiology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, PolandDepartment of Pathology, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland1st Department of Lung Diseases, National Research Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, PolandA Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain. Furthermore, there is a possibility of protracted SARS-CoV-2 infection and the need for repeated antiviral treatment. Monoclonal antibodies against CD20, which are used, among other things, in the therapy of chronic lymphocytic leukaemia and follicular lymphoma, can induct immunosuppression. We present a case report of a patient with follicular lymphoma, treated with obinutuzumab, who was diagnosed with prolonged, ongoing SARS-CoV-2 infection and related organizing pneumonia. The recognition and the treatment were challenging which makes this case noteworthy. Antiviral therapy with several medications was administrated to our patient and their temporary, positive effect was observed. Moreover, high-dose intravenous immunoglobulin was applied, because slowly decreasing IgM and IgG levels were observed. The patient also received standard treatment of organizing pneumonia. We believe that such a complex approach can create an opportunity for recovery. Physicians should be conscious of the course and treatment possibilities facing similar cases.https://www.mdpi.com/1999-4915/15/3/693prolonged SARS-CoV-2 infectionCOVID-19obinutuzumaborganizing pneumonia
spellingShingle E. Łyżwa
M. Sobiecka
K. Lewandowska
I. Siemion-Szcześniak
I. Barańska
M. Klatt
R. Langfort
M. Szturmowicz
W. Tomkowski
Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
Viruses
prolonged SARS-CoV-2 infection
COVID-19
obinutuzumab
organizing pneumonia
title Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
title_full Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
title_fullStr Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
title_full_unstemmed Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
title_short Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab—Challenging Recognition and Treatment
title_sort prolonged sars cov 2 infection and organizing pneumonia in a patient with follicular lymphoma treated with obinutuzumab challenging recognition and treatment
topic prolonged SARS-CoV-2 infection
COVID-19
obinutuzumab
organizing pneumonia
url https://www.mdpi.com/1999-4915/15/3/693
work_keys_str_mv AT ełyzwa prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT msobiecka prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT klewandowska prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT isiemionszczesniak prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT ibaranska prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT mklatt prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT rlangfort prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT mszturmowicz prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment
AT wtomkowski prolongedsarscov2infectionandorganizingpneumoniainapatientwithfollicularlymphomatreatedwithobinutuzumabchallengingrecognitionandtreatment